Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ovid Therapeutics Inc. - Common Stock
(NQ:
OVID
)
1.630
+0.070 (+4.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,429,740
Open
1.560
Bid (Size)
1.600 (20)
Ask (Size)
1.650 (3)
Prev. Close
1.560
Today's Range
1.560 - 1.650
52wk Range
0.2425 - 2.010
Shares Outstanding
70,417,345
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Curious about the stocks that are showing activity after the closing bell on Friday?
October 03, 2025
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why
October 03, 2025
The company is now looking forward to initiating a mid-stage study evaluating OV329 in adult patients with drug-resistant focal onset seizures.
Via
Stocktwits
Topics
Intellectual Property
Performance
YTD
+70.1%
+70.1%
1 Month
-5.8%
-5.8%
3 Month
+209.0%
+209.0%
6 Month
+365.7%
+365.7%
1 Year
+39.3%
+39.3%
More News
Read More
These stocks that are showing activity before the opening bell on Friday.
October 03, 2025
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 03, 2025
Via
Benzinga
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
October 03, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
October 03, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Tuesday?
September 02, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 13, 2025
Via
Benzinga
Top movers in Wednesday's session
August 13, 2025
Via
Chartmill
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
August 13, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
July 23, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Which stocks are moving after the closing bell on Tuesday?
July 22, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
July 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 27, 2025
Via
Benzinga
Get insights into the top gainers and losers of Friday's after-hours session.
June 27, 2025
Via
Chartmill
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
June 05, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
May 13, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
April 24, 2025
Via
Benzinga
Top movers in Wednesday's after hours session
April 23, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 23, 2025
Via
Benzinga
Top movers in Wednesday's pre-market session
April 09, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 09, 2025
Via
Benzinga
Frequently Asked Questions
Is Ovid Therapeutics Inc. - Common Stock publicly traded?
Yes, Ovid Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Ovid Therapeutics Inc. - Common Stock trade on?
Ovid Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ovid Therapeutics Inc. - Common Stock?
The ticker symbol for Ovid Therapeutics Inc. - Common Stock is OVID on the Nasdaq Stock Market
What is the current price of Ovid Therapeutics Inc. - Common Stock?
The current price of Ovid Therapeutics Inc. - Common Stock is 1.630
When was Ovid Therapeutics Inc. - Common Stock last traded?
The last trade of Ovid Therapeutics Inc. - Common Stock was at 10/24/25 04:00 PM ET
What is the market capitalization of Ovid Therapeutics Inc. - Common Stock?
The market capitalization of Ovid Therapeutics Inc. - Common Stock is 114.78M
How many shares of Ovid Therapeutics Inc. - Common Stock are outstanding?
Ovid Therapeutics Inc. - Common Stock has 115M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.